ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2013

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

8,100Medicare Part D Prescriptions Filled, Including Refills

Rank: 53 out of 247

$566K Total Retail Price of All Prescriptions

Rank: 35 out of 247

684 Patients Receiving at Least One Drug in Part D
80% Patients 65 Years and Older
41% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg 81928cdb0ebe162ff75cf405bfacadd396bf3ec84bc467b6f3e612dd63daa776 Average for
this specialty
in New Mexico
Lower avg 72b1978e1dcc0b845f89d17d692cfff7aeaf8d8bce70310d8bfc535db2daf62a

Schedule Two
Controlled Substances

10% of this provider’s 684 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

11% of this provider’s 684 patients filled at least one prescription for a schedule three drug, compared to an average of 11%.

Brand Name Drugs

18% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$70 was the average price of a prescription from this provider, compared to $63 among peers.

Prescriptions per Patient

12 is the average number of prescriptions (including refills) per patient, compared to an average of 15.


This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

B

A benzodiazepine, or tranquilizer. More » The American Geriatrics Society says these drugs increase the risk of cognitive impairment, delirium, falls and fractures in older adults.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled with Refills Prescriptions
to 65+
Patients Recieving this Drug Category For this Prescriber For All Prescribers in
This Specialty in New Mexico
SIMVASTATIN 413 372 144 1 3
HYDROCODONE-ACETAMINOPHEN 347 256 71 S3 2 7
LEVOTHYROXINE SODIUM 346 310 111 3 1
ATORVASTATIN CALCIUM 306 265 120 4 8
LISINOPRIL 305 264 98 5 2
METFORMIN HCL 300 261 97 6 6
LISINOPRIL-HYDROCHLOROTHIAZIDE 263 234 86 7 34
OMEPRAZOLE 258 193 90 8 5
AMLODIPINE BESYLATE 225 203 80 9 4
ZOLPIDEM TARTRATE 203 174 48 10 23
GABAPENTIN 149 115 52 11 11
METOPROLOL SUCCINATE 141 125 43 12 14
OXYCODONE-ACETAMINOPHEN 137 79 22 S2 13 54
LORAZEPAM 136 113 40 B 14 40
GLIPIZIDE 133 118 42 15 39
NAPROXEN 126 91 55 16 84
CITALOPRAM HBR 105 93 38 17 22
HYDROCHLOROTHIAZIDE 102 91 37 18 10
PRAVASTATIN SODIUM 99 94* 39 19 27
FUROSEMIDE 97 67 42 20 9
TRAMADOL HCL 95 74 24 21 28
CRESTOR 93 78 31 22 38
IBUPROFEN 91 74 32 23 50
WARFARIN SODIUM 91 77 29 23 16
OXYCODONE HCL-ACETAMINOPHEN 77 <11 <11 S2 25 77
ALLOPURINOL 75 70* 25 26 30
LANTUS SOLOSTAR 71 66* 14 27 68
LOSARTAN-HYDROCHLOROTHIAZIDE 68 63* 21 28 63
SPIRIVA 67 67 15 29 67
MORPHINE SULFATE ER 66 <11 <11 S2 30 69
DOXAZOSIN MESYLATE 65 60* 18 31 58
CYCLOBENZAPRINE HCL 61 28 19 R 32 87
ATENOLOL 60 55* 18 33 20
PREDNISONE 58 43 30 34 37
CARVEDILOL 57 52* 19 35 31
FLUOCINONIDE 57 52* 30 35 192
JANUVIA 57 <11 <11 35 48
FLUTICASONE PROPIONATE 57 52* 26 35 19
MELOXICAM 57 52* 23 35 44
PROAIR HFA 56 40 28 40 41
OXYCODONE HCL 56 19 19 S2 40 36
CLONIDINE HCL 55 55 14 42 80
TAMSULOSIN HCL 53 48* 19 43 21
ADVAIR DISKUS 53 42 13 43 58
CLONAZEPAM 52 47* 11 B 45 70
About This Data

Prescribing data from Medicare’s prescription drug benefit, known as Part D, was compiled and released by the Centers for Medicare and Medicaid Services, the federal agency that oversees the program. ProPublica combined that data with additional information released by CMS. The data for 2013 includes nearly 1.4 billion prescriptions written by 1.3 million doctors, nurses and other providers. This database lists about 410,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths of these prescriptions went to patients 65 and older; the rest were for disabled patients Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to checkup@propublica.org and we will update your information. If you have other questions about this data, send a note to checkup@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on April 20, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.